Tag ~drug discovery

Tag descriptions coming soon to Wherrelz News!


Verana Health aims to organize and analyze doctors clinical data sets whether patients like it or not

DeepMinds latest AlphaFold model is more useful for drug discovery

Alphabets AI drug discovery platform Isomorphic Labs raises 600M from Thrive

UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome

Meta Pharmaceuticals lands 15M to make autoimmune drugs with AI new immunometabolism tech

Gandeeva Therapeutics raises 40m zoom in on biomolecules and create new drugs in the process

uBiome is jumping into therapeutics with a healthy 83 million in Series C financing

On the heels of a 40 million round TriNetX brings its services for drug trials to Europe

What It Takes to Design a Bioprinter for Cancer Research from Inventia Life Sciences

Brightseeds first AIdetected phytonutrient comes to market alongside a 68M B round

The genomicsfocused Illumina Accelerator backs five new companies

With new Partner Colin Hanna and Shikha Ahluwalia as Associate Balderton puts down roots in Berlin

TLDR on location: Prime Day breaks record Bill Gates invests in Alzheimers initiative Wanderlust Society

With new funding Atomic AI envisions RNA as the next frontier in drug discovery

Longevity startup Gero AI has a mobile API for quantifying health changes

Keith Murphy: We Believe We are Discovering the Next Step in Drug Development

Shares of protein discovery platform Absci pop in market debut

regenHU and Wako Automation Promoting Drug Discovery and 3D Bioprinting in the US

Reid Hoffmans Manas AI raises 246M a fraction of other AI drug discovery startups

NewLimit founded by Coinbase CEO Brian Armstorng raises 130M to develop agereversing treatments

Healx an AIenabled drug discovery platform for rare diseases raises 47M

BICO Granted Bioprinting Patents That Improve Cell Viability and Reproducibility

Journey Clinical raises 3M to allow psychotherapists to prescribe psychedelics

Adaptive and Illumina to make immune sequencing kits for labs streamlining the detection of disease

Generate Biomedicines raises 370M Series B with a focus on proteinbased drugs

Biogelx in Brazil: New Collaboration for Research Tissue Bioprinting Inks

Bioprinting Strategies: The Robin Hoods of Wake Forest

Potential new treatment for COVID19 uncovered by BenevolentAI enters trials

Medable reaches 21B valuation as Tiger Blackstone GSR pump new capital into clinical trials management company

Heart disease is the worlds biggest killer this Cambridge Uni spinout is using AI to find new treatments

Implantable 3D printed organs could be coming sooner than you think

French biotech Generare speeds up hunt for new drugs by cloning natural molecules

Artificial Intelligence Technology Drives Within the life Sciences Industry

Sydney Bioprinting Firm Closes 25M Series B Round

Formation Bio raises 372M to boost drug development with AI

UK biotech startup Mogrify injects 16M to get novel cell therapies to market soon

Weed in space is going to be a thing now

Bit Bios enter button for the keyboard to the software of life nabs the company 415 million

Emerging from stealth Octant is bringing the tools of synthetic biology to large scale drug discovery

Aqemia raises 38M to find new drugs by meshing theoretical physics with GenAI

The health data transparency movement is birthing a new generation of startups

How can you understand life if you dont look at it live Eikon Therapeutics rakes in 518M

Aramcos Prosperity7 powers AI drug firm Insilicos 95M round

Isomorphic Labs is Alphabets play in AI drug discovery

NewLimit founded by Coinbase CEO Brian Armstrong raises 130M to develop agereversing treatments

Eden Tech Microlight3D Collaborate on Nano 3D Printing for Microfluidics

NFXbacked Pepper Bio Emerges from stealth with tools to hone in on complex diseases

Engine Biosciences expands its digital drug discovery pipeline with 43M round

Brightseeds first AIdetected phytonutrient comes to market alongside a 68M A round

6 questions investors should ask when evaluating psychedelic biotech companies